April 19, 2024
A constructing on the Illumina Campus in College Metropolis. Reuters/Mike Blake

Most cancers check maker Grail mentioned on Friday that its telemedicine vendor erroneously despatched letters to about 400 sufferers suggesting they might have developed most cancers.

Grail’s flagship most cancers detection blood check Galleri is designed to detect greater than 50 forms of most cancers earlier than signs seem.

The corporate, owned by San Diego-based Illumina, mentioned the letters had been mistakenly despatched by PWNHealth attributable to a software program challenge and that it “was by no means associated to or attributable to an incorrect Galleri check consequence”.

Grail mentioned it had reached out to the sufferers instantly after the problem, including that no affected person well being data has been disclosed or breached attributable to this.

The software program challenge being confronted by PWNHealth has now been resolved, it mentioned.

Illumina is presently interesting regulatory orders in the USA and European Union, that are asking the gene sequencing firm to divest Grail after it jumped regulators to shut its acquisition of the most cancers check maker.